BMO Capital analyst Benjamin Mayhew lowered the firm’s price target on Vital Farms (VITL) to $50 from $60 and keeps an Outperform rating on the shares after attending the company’s Investor Day. The firm cites the company’s FY25 outlook being revised lower, but while the reduced guidance is disappointing, the cut reflects temporary disruption that Vital already has worked through as evidenced by in-line 2026 outlook, the analyst tells investors in a research note. Given the company’s achievable low-20% long-term revenue CAGR, the stock remains highly attractive at current valuation, BMO added.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VITL:
- Vital Farms price target lowered to $45 from $48 at Morgan Stanley
- Midday Fly By: Ford takes $19.5B EV writedown, Apple expanding iPhone lineup
- Vital Farms: Long-Term Growth Potential Outweighs Minor Short-Term Revenue Adjustment
- Morning Movers: Vital Farms dips after cutting FY25 revenue view
- Vital Farms Sets Ambitious 2030 Financial Targets
